Search research articles
Contact Us
Filters
Showing results (31-40 of 138) with videos related to
Page
of 14
Sort By:
Bladder Cancer (Amsterdam, Netherlands)
|
July 12, 2024
Comparative Analysis of Very Reduced vs Full Dose BCG Treatment for High-Risk Non-Muscle Invasive Bladder Cancer: A Contemporary Experience from Chile
Valentina Grajales, Roberto Contieri, Wei Shen Tan, et al.
BJU International
|
May 22, 2024
Assessing long-term upgrade risks in recurrent low-grade non-muscle-invasive bladder cancer, can we deintensify the treatment?
Alessio Finocchiaro, Marco Paciotti, Roberto Contieri, et al.
The Journal of Urology
|
August 25, 2023
Reply by Authors
Wei Shen Tan, Roberto Contieri, Nicolò Maria Buffi, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology
|
February 5, 2025
Advancing Surgical Management of Penile Cancer: Single Port Bilateral Inguinal Lymph Node Dissection
Sisto Perdonà, Alessandro Izzo, Antonio Tufano, et al.
The Journal of Urology
|
August 3, 2023
International Bladder Cancer Group Intermediate-risk Nonmuscle-invasive Bladder Cancer Scoring System Predicts Outcomes of Patients on Active Surveillance
Wei Shen Tan, Roberto Contieri, Nicolò Maria Buffi, et al.
BJUI Compass
|
April 27, 2022
Intravesical gemcitabine as bladder-preserving treatment for BCG unresponsive non-muscle-invasive bladder cancer. Results from a single-arm, open-label study
Rodolfo Hurle, Paolo Casale, Emanuela Morenghi, et al.
European Urology Open Science
|
August 2, 2021
Long-term Follow-up After En Bloc Transurethral Resection of Non-muscle-invasive Bladder Cancer: Results from a Single-center Experience
Marco Paciotti, Paolo Casale, Piergiuseppe Colombo, et al.
European Urology Focus
|
January 10, 2024
The Financial Burden of Guideline-recommended Cancer Medications for Metastatic Urothelial Carcinoma
Roberto Contieri, Alberto Martini, Laura S Mertens, et al.
European Urology Oncology
|
June 1, 2021
Long-term Follow-up and Factors Associated with Active Surveillance Failure for Patients with Non-muscle-invasive Bladder Cancer: The Bladder Cancer Italian Active Surveillance (BIAS) Experience
Roberto Contieri, Marco Paciotti, Giovanni Lughezzani, et al.
Minerva Urology and Nephrology
|
August 2, 2021
Active surveillance for recurrent non-muscle invasive bladder cancer: which lessons have we learned during COVID-19 pandemic?
Marco Paciotti, Roberto Contieri, Vittorio Fasulo, et al.
Page
of 14
Search research articles
Search
Showing results (31-40 of 138) with videos related to
Sort By:
Page
of 14
Bladder Cancer (Amsterdam, Netherlands)
|
July 12, 2024
Comparative Analysis of Very Reduced vs Full Dose BCG Treatment for High-Risk Non-Muscle Invasive Bladder Cancer: A Contemporary Experience from Chile
Valentina Grajales, Roberto Contieri, Wei Shen Tan, et al.
BJU International
|
May 22, 2024
Assessing long-term upgrade risks in recurrent low-grade non-muscle-invasive bladder cancer, can we deintensify the treatment?
Alessio Finocchiaro, Marco Paciotti, Roberto Contieri, et al.
The Journal of Urology
|
August 25, 2023
Reply by Authors
Wei Shen Tan, Roberto Contieri, Nicolò Maria Buffi, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology
|
February 5, 2025
Advancing Surgical Management of Penile Cancer: Single Port Bilateral Inguinal Lymph Node Dissection
Sisto Perdonà, Alessandro Izzo, Antonio Tufano, et al.
The Journal of Urology
|
August 3, 2023
International Bladder Cancer Group Intermediate-risk Nonmuscle-invasive Bladder Cancer Scoring System Predicts Outcomes of Patients on Active Surveillance
Wei Shen Tan, Roberto Contieri, Nicolò Maria Buffi, et al.
BJUI Compass
|
April 27, 2022
Intravesical gemcitabine as bladder-preserving treatment for BCG unresponsive non-muscle-invasive bladder cancer. Results from a single-arm, open-label study
Rodolfo Hurle, Paolo Casale, Emanuela Morenghi, et al.
European Urology Open Science
|
August 2, 2021
Long-term Follow-up After En Bloc Transurethral Resection of Non-muscle-invasive Bladder Cancer: Results from a Single-center Experience
Marco Paciotti, Paolo Casale, Piergiuseppe Colombo, et al.
European Urology Focus
|
January 10, 2024
The Financial Burden of Guideline-recommended Cancer Medications for Metastatic Urothelial Carcinoma
Roberto Contieri, Alberto Martini, Laura S Mertens, et al.
European Urology Oncology
|
June 1, 2021
Long-term Follow-up and Factors Associated with Active Surveillance Failure for Patients with Non-muscle-invasive Bladder Cancer: The Bladder Cancer Italian Active Surveillance (BIAS) Experience
Roberto Contieri, Marco Paciotti, Giovanni Lughezzani, et al.
Minerva Urology and Nephrology
|
August 2, 2021
Active surveillance for recurrent non-muscle invasive bladder cancer: which lessons have we learned during COVID-19 pandemic?
Marco Paciotti, Roberto Contieri, Vittorio Fasulo, et al.
Page
of 14